On Monday, the United States regulators gave complete approval to the coronavirus vaccine of Pfizer, possibly boosting public confidence in the doses and immediately opening the way for more companies, universities, and other local governments to make vaccinations mandatory.
Moreover, the Pentagon announced that it would press ahead with strategies to urge military members to receive vaccination amid the fight against the more contagious delta variant. Likewise, the University of Minnesota said it would require its students to get the dose, as did major public universities of Louisiana, including LSU, yet state law there allows extensive exemptions.
Over two hundred million Pfizer shots administered in the United States under emergency provisions – and a large number globally – since December 2020. Going one step ahead and approving full approval, the Food and Drug Administration (FDA) mentioned some months of evidence that severe side effects are infrequent.
Joe Biden, the President of the States, said that for those people who hesitated to receive the vaccine dose until it received what he dubbed the gold standard of Food and Drug Administration approval. But, the president added, get vaccinated today.
Let me say this loud and clear: If you are one of the millions of Americans who have said that you will get the shot when it had full FDA approval — that has now happened.
The moment you have been waiting for is here — and the time to get vaccinated is today.
— President Biden (@POTUS) August 23, 2021
Milestone of Pfizer
Albert Bourla, the CEO of Pfizer, called the approval from FDA an important milestone that will crack some of the more skeptical minds. Pfizer said that the United States is the first country to grant full and final approval of its vaccine to combat coronavirus, in a process that required three hundred sixty-thousand-page application and tough inspections. Before that, the FDA has no too much evidence to judge the safety of the dose.
The vaccine’s formula, mutually developed with BioNTech of Germany, will mark under the brand name Comirnaty. Moderna also applied for its vaccine to the FDA’s full approval. On the other hand, Johnson & Johnson, the third vaccine option in the United States, said it hopes to apply for full approval later this year. Just more than half of the American population received the full dose of vaccination.
What is FDA Full Approval of Vaccine?
Vaccination in the United States bottomed out last month at an average of around a half-million doses per day, down from the highest of 3.4 million per day in mid-April. However, as the contagious delta variant boosts the number of hospitalizations in the country, vaccine doses are on the increase again, with a million per day given Thursday, Friday, and Saturday.
Full approval of the coronavirus vaccine of Pfizer means it meets the same very high standards needed of all the recommended vaccines. A former FDA vaccine chief, Dr. Jesse Goodman of Georgetown University, said that anybody who still has concerns gains confidence in the doses.
Earlier this month, Lloyd Austin, the Defense Secretary, stated that he would seek the approval of Biden to make the vaccine mandatory by September mid or once the Food & Drug Authority gave final approval, which overcomes first. Furthermore, the approval opened the way for immediate action by colleges to involve coronavirus vaccines and set the legal ground for hundreds of universities that already issued mandates for staff members and students.
In recent weeks, the delta variant drove the new cases, deaths, and hospitalizations at new peaks in the United States, erasing months of development. Deaths are running at around one thousand per day on average for the first time since mid-March, and new cases are averaging one hundred forty-seven thousand per day, a level last observed at the January end.